Abstract: Fifty-four billion dollars was spent on alcohol/ drug abuse and mental health treatment in 1990. These expenditures were concentrated in the area of inpatient psychiatric care and on persons with severe mental health and substance abuse problems. The data on expenditure patterns for mental health and substance abuse care suggest that successful health care reform in this area must implement mechanisms for controlling inpatient utilization and managing the care of persons with the most severe disorders. P resident Clinton's proposal for health reform contains a plan for changing dramatically the manner in which mental health and substance abuse services are financed and delivered in the United States. The plan calls for eventual full integration of mental health/ substance abuse coverage with the rest of health care. 1 Assessing the impact of such changes is complicated and depends on critical implementation decisions to be made over the next several years during a phase-in of the president's health reform plan. Thus, we cannot yet make comprehensive projections regarding the impact of the fully integrated system. The purpose of this DataWatch is twofold: (1) to provide a framework for undertaking a quantitative impact analysis in the future; and (2) to provide data that underscore the challenges for the phase-in period of health reform. We focus our attention specifically on the challenges for payment policy and public financing of mental health/ substance abuse care within a reformed health care system.
Financing Mental Health/Substance Abuse Care: The Baseline
We organize the data by population segments and by the type of insurance coverage that currently is in place. Since the coverage provisions differ dramatically across population groups, we expect the impact of health reform to vary also.
Baseline data. The basic building block of this analysis is the estimates of Dorothy Rice and colleagues of the direct costs of alcohol/ drug abuse and mental (ADM) disorders. 2 These estimates are based on utilization and expenditure data and thus exclude administrative costs. We did not count support costs and 90 percent of nursing home costs (which are those accounted for by people age sixty-five and older, who are unlikely to be included in health care reform). We also deducted from the numbers the prevention and data development set-asides in the federal ADM Block Grant. These deductions were $20.9 million for mental health and $225.6 million for substance abuse. 3 The allocations between alcohol and drug abuse were made according to the distributions reported in the Rice study. We also eliminated $4.3 billion in ADM costs stemming from comorbid physical conditions (for example, a portion of liver transplants can be linked to alcohol abuse). Costs associated with forensic hospital care in state mental hospitals also were deducted from the state mental health expenditures, $0.7 billion in 1990. 4 After these adjustments, ADM costs totaled $54 billion in 1990 (see Exhibit 1) .
We then divided the total expenditures among sources of payment. Using data from the Center for Mental Health Services (CMHS) inventory and the National Drug and Alcoholism Treatment Unit Survey (NDATUS), we allocated $2.2 billion to Medicare. Medicaid dollars were based on the high estimate of the range identified by George Wright and Jeffrey Buck, trended forward to 1990 dollars.5 The high end was chosen because since 1984 the advent of disproportionate-share rules has increased Medicaid payments associated with ADM disorders. The Medicaid total was $9.5 billion in 1990. Medicaid dollars were allocated to ADM accord- ing to the aggregate proportions found by Rice and colleagues. Privatesource expenses consist of total spending, out-of-pocket payments, insurance expenses, and philanthropy. Some adjustment was made to the private-source expenses reported by the Rice study based on more recent data from the Substance Abuse and Mental Health Services Administration (SAMHSA). 6 The Department of Veterans Affairs (VA) share was based on 1990 data from the CMHS inventory and data on substance abuse care from the VA. State and local data also were derived from data from the CMHS inventory and NDATUS. The "other federal" category is defined as a residual of federal funds. Exhibit 1 summarizes the distribution of baseline costs by payer source.
Population groups. In 1990 there were 22.1 million Medicaid eligibles and 31.2 million people age sixty-five and older who were assigned to Medicare. 7 We assume that there were thirty-five million uninsured persons, 16 percent of whom had a serious mental health/ substance abuse problem. 8 The private-source population constitutes the remainder. Baseline per capita estimates. We used the four population groups defined above to estimate baseline per capita costs for each group (Exhibit 2). For the privately insured and Medicaid and Medicare population groups, we divided expenditures by the size of the group. Costs from the VA, costs of state and local governments, and other federal costs were allocated to the uninsured.
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Observations And Lessons
Observations. Exhibit 3 shows that for the entire U.S. population, we 10 Exhibit 2 shows that mental health/ substance abuse services to the uninsured accounted for roughly $20.1 billion in 1990 ($575 times thirty-five million people). A substantial portion of this (about 89 percent) represents expenditures made on behalf of persons with serious mental health/ substance abuse problems.
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A related analysis of direct costs for patients with the most severe mental illnesses in the public and private sectors estimated that $20 billion was spent in 1990 for their treatment. Challenges. Three important challenges for health care reform emerge from the data presented. The first stems from the composition of expenditures. The heavy reliance on inpatient mental health/ substance abuse care suggests that successful cost control depends on mechanisms to manage and control inpatient use. Health plans that have successfully found alternatives to inpatient care and that have created financial incentives for decreased inpatient utilization have been able to pay for increased use of community-based services through savings from inpatient psychiatric care.1 3 Failure to control inpatient use threatens the creation of an integrated system of mental health/ substance abuse care given current budgetary politics.
The second important challenge stems from the fact that individuals with severe mental illnesses and substance abuse disorders consume a large share of total mental health/ substance abuse resources. We estimate that two-fifths of all mental health/ substance abuse expenditures are made on behalf of roughly 2 percent of the population. Full integration of mental health/ substance abuse care means developing systems within health plans that can efficiently manage the complex and extensive treatment needs of people with severe mental health/ substance abuse illnesses. Moreover, it means developing a method of paying health plans that allocate dollars to mental health programs for the treatment of the severely ill and guarding against incentives to under-treat these vulnerable populations.
The third challenge is to implement an integrated mental health/ substance abuse benefit within the framework of managed competition that is fair to all citizens. How can the existing variation in public financing of mental health/ substance abuse care be accommodated within a national uniform benefit? A financing mechanism must be created to allocate fairly the burden of moving to an integrated mental health/ substance abuse system across the entire polity.
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